ketamine intravenous infusion

DRUG3 trials

Sponsors

NeuroRx, Inc., Wake Forest University Health Sciences, Assiut University

Conditions

Bipolar DepressionOrofacial PainSuicidal IdeasSuicidal IdeationSuicide, AttemptedTobacco Use Disorder

Phase 1

The Effects of Sedatives on Tobacco Use Disorder

CompletedNCT03813121

Wake Forest University Health SciencesTobacco Use Disorder

Start: 2019-06-01End: 2021-08-31Updated: 2022-10-06

Phase 2

Sequential Therapy for the Treatment of Severe Bipolar Depression.

CompletedNCT02974010

NeuroRx, Inc.Bipolar Depression, Suicidal Ideas, Suicidal Ideation +1

Start: 2018-01-15End: 2019-11-20Updated: 2021-05-25

Safety and Efficacy of Lidocaine Versus Ketamine Infusion for Resistant Orofacial Pain

Not yet recruitingNCT07250867

Assiut UniversityOrofacial Pain

Start: 2026-01-31End: 2027-02-28Target: 105Updated: 2025-11-26

Related Papers

NRX-101 (D-cycloserine plus lurasidone) vs. lurasidone for the maintenance of initial stabilization after ketamine in patients with severe bipolar depression with acute suicidal ideation and behavior: a randomized prospective phase 2 trial.

2023-08-1315 citations